Full text loading...
-
Hemisynthesis, Anti-Inflammatory, and In-silico Alpha-Amylase Inhibition of Novel Carlina Oxide Analogs
- Source: Current Chemical Biology, Volume 18, Issue 4, Dec 2024, p. 249 - 258
-
- 27 Mar 2024
- 06 Sep 2024
- 23 Oct 2024
Abstract
Numerous natural products have been successfully developed for clinical use in the treatment of human diseases in almost every therapeutic area.
This work aimed to synthesize some new analogs of carlina oxide by functionalizing the fifth position of the furan by different acyl groups using the Friedel-Crafts acylation approach. The synthetic analogs and carlina oxide were then assessed for their in-vitro anti-inflammatory activity and in-silico alpha-amylase inhibition effect.
The new analogs were synthesized at room temperature using different anhydrides with the presence of boron trifluoride diethyl etherate (BF3-Et2O) as an acid catalyst. A protein denaturation assay was performed to evaluate the anti-inflammatory activity, while the in-silico study was conducted using the Molecular Operating Environment (MOE) with different types of alpha-amylase sources, such as human salivary pancreatic alpha-amylase and Aspergillus oryzae alpha-amylase (PDB: 1Q4N, 5EMY, 7P4W respectively).
A total of four analogs of carlina oxide were obtained in yields of 60-7% and then identified with 1H and 13C NMR analysis. Additionally, analog 1 exhibited a better anti-inflammatory effect with an IC50 of 0.280 mg/mL. However, the in-silico study showed that all the synthetic analogs have different interactions with human salivary alpha-amylase (1Q4N) and other interactions with 5EMY and 7P4W.
The new analogs of carlina oxide have the potential to serve as an alternative agent for alpha-amylase inhibition, contributing to the reduction of postprandial hyperglycemia.